Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow clinical trial (NCT00172068). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of zoledronic acid?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow clinical trial (NCT00172068). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow clinical trial (NCT00172068). Contact the study team or your healthcare provider for specific answers.

Question 4

What does the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow clinical trial (NCT00172068). Contact the study team or your healthcare provider for specific answers.

Question 5

What can I expect during the trial in terms of monitoring and follow-up?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow clinical trial (NCT00172068). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow clinical trial (NCT00172068). Contact the study team or your healthcare provider for specific answers.

What this study is about